Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.1K Buy
5,395
+3,281
+155% +$18.4K ﹤0.01% 8146
2026
Q2
$12.9K Sell
2,114
-268
-11% -$2.06K ﹤0.01% 8421
2026
Q1
$16.6K Buy
+2,382
New +$18.2K ﹤0.01% 8068

Other funds holding BRAI

UBS Group's BRAI Position: Q3 2026 in Review

UBS Group increased its Braiin (BRAI) stake by 155% in Q3 2026, buying an estimated $18.4K and bringing the position to 5,395 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #8146.

UBS Group first reported a position in BRAI in Q1 2026 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold BRAI as of Q3 2026.

  • UBS Group held 5,395 shares of Braiin worth $29.1K as of Q3 2026.
  • UBS Group bought 3,281 Braiin shares in Q3 2026, an estimated $18.4K.
  • Braiin made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8146 holding.
  • UBS Group first reported a position in Braiin in Q1 2026 and has held it in 3 quarters since.
  • 10 funds tracked by Wall St. Rank held Braiin as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.